Literature DB >> 33501430

The brain tumor not-for-profit and charity experience of COVID-19: reacting and adjusting to an unprecedented global pandemic in the 21st century.

Christina Amidei1, Jean Arzbaecher2, Mary Ellen Maher3, Christine Mungoshi4, Rosemary Cashman5, Stuart Farrimond6, Carol Kruchko7, Chris Tse6, Maureen Daniels8, Sharon Lamb6, Anita Granero9, Mary Lovely10, Jenifer Baker6, Sally Payne6, Kathy Oliver6.   

Abstract

BACKGROUND: The Coronavirus Disease 2019 (COVID-19) pandemic has affected individuals as well as disease-specific brain tumor organizations. These organizations around the world exist to address unmet needs for patients and caregivers they serve. The direct impact of the pandemic on these organizations constitutes significant collateral damage. In order to better understand the effects of the COVID-19 pandemic on brain tumor organizations, the International Brain Tumour Alliance (IBTA) carried out an international survey to identify organizational changes induced by the virus and approaches adopted to address challenges.
METHODS: A 37-question online survey consisting of categorical and qualitative questions was developed and circulated to 130 brain tumor organizations across the world. Seventy-seven organizations from 22 countries completed the survey (59% return rate). Descriptive statistics and content analysis were used to present the results.
RESULTS: Responses fell into the following 3 categories: (1) organizational characteristics, (2) impact of COVID-19 on services, and (3) COVID-19 impact on financial and human resources within organizations. Although organizational characteristics varied, common concerns reported were activity disruption which impacted organizations' abilities to offer usual services and challenges to sustaining funding. Both financial and human resources were stressed, but integral adaptations were made by organizations to preserve resources during the pandemic.
CONCLUSIONS: Although brain tumor organizations have been impacted by the COVID-19 pandemic, organizations quickly adjusted to this unprecedented global healthcare crisis. Nimble reactions and flexibility have been vital to organization sustainability. Innovative approaches are required to ensure organizations remain viable so that needs of brain tumor community at large are met.
© The Author(s) 2020. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

Entities:  

Keywords:  COVID-19; brain tumor organization; support services

Year:  2020        PMID: 33501430      PMCID: PMC7798794          DOI: 10.1093/noajnl/vdaa166

Source DB:  PubMed          Journal:  Neurooncol Adv        ISSN: 2632-2498


  7 in total

1.  COVID-19 and cancer research.

Authors:  Adrian L Harris
Journal:  Br J Cancer       Date:  2020-06-26       Impact factor: 7.640

Review 2.  Business as usual? Psychological support at a distance.

Authors:  Lara Payne; Halina Flannery; Chandrika Kambakara Gedara; Xeni Daniilidi; Megan Hitchcock; Danielle Lambert; Charlotte Taylor; Deborah Christie
Journal:  Clin Child Psychol Psychiatry       Date:  2020-06-27       Impact factor: 2.544

3.  An invited commentary on "The socio-economic implications of the coronavirus and COVID-19 pandemic: A review".

Authors:  Shaul Atar; Itai Atar
Journal:  Int J Surg       Date:  2020-04-29       Impact factor: 6.071

4.  Areas of academic research with the impact of COVID-19.

Authors:  Abid Haleem; Mohd Javaid; Raju Vaishya; S G Deshmukh
Journal:  Am J Emerg Med       Date:  2020-04-15       Impact factor: 2.469

Review 5.  Enhancing relationships through technology: directions in parenting, caregiving, romantic partnerships, and clinical practice
.

Authors:  Margaret E Morris
Journal:  Dialogues Clin Neurosci       Date:  2020-06       Impact factor: 5.986

6.  Organisations for patients with cancer feel the brunt of COVID-19 pandemic.

Authors:  Roxanne Nelson
Journal:  Lancet Oncol       Date:  2020-07-10       Impact factor: 41.316

Review 7.  The socio-economic implications of the coronavirus pandemic (COVID-19): A review.

Authors:  Maria Nicola; Zaid Alsafi; Catrin Sohrabi; Ahmed Kerwan; Ahmed Al-Jabir; Christos Iosifidis; Maliha Agha; Riaz Agha
Journal:  Int J Surg       Date:  2020-04-17       Impact factor: 6.071

  7 in total
  3 in total

1.  Brain tumor patients and COVID-19 vaccines: results of an international survey.

Authors:  Mathew R Voisin; Kathy Oliver; Stuart Farrimond; Tess Chee; Philip O'Halloran; Martin Glas; Gelareh Zadeh
Journal:  Neurooncol Adv       Date:  2022-05-03

2.  The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment.

Authors:  Maciej M Mrugala; Quinn T Ostrom; Shelley M Pressley; Jennie W Taylor; Alissa A Thomas; Jeffrey S Wefel; Scott L Coven; Alvina A Acquaye; Chas Haynes; Sameer Agnihotri; Michael Lim; Katherine B Peters; Erik P Sulman; Joanne T Salcido; Nicholas A Butowski; Shawn Hervey-Jumper; Alireza Mansouri; Kathy R Oliver; Alyx B Porter; Farshad Nassiri; David Schiff; Erin M Dunbar; Monika E Hegi; Terri S Armstrong; Martin J van den Bent; Susan M Chang; Gelareh Zadeh; Milan G Chheda
Journal:  Neurooncol Adv       Date:  2021-02-20

Review 3.  How has the COVID-19 pandemic impacted clinical care and research in Neuro-Oncology?

Authors:  Angus Airth; James R Whittle; James Dimou
Journal:  J Clin Neurosci       Date:  2022-09-08       Impact factor: 2.116

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.